SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-050140
Filing Date
2007-03-09
Accepted
2007-03-09 06:23:08
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1209832
2 MONOGRAM NON-QUALIFIED DEFERRED COMPENSATION PLAN, EFFECTIVE JANUARY 1,2007 dex1044.htm EX-10.44 250260
3 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex231.htm EX-23.1 1846
4 CONSENT OF ERNST & YOUNG LLP dex232.htm EX-23.2 1900
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) dex311.htm EX-31.1 9255
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) dex312.htm EX-31.2 9272
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex321.htm EX-32.1 4868
8 GRAPHIC g65979img001.jpg GRAPHIC 102751
  Complete submission text file 0001193125-07-050140.txt   1630468
Mailing Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650.635.1100
Monogram Biosciences, Inc. (Filer) CIK: 0001094961 (see all company filings)

IRS No.: 943234479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30369 | Film No.: 07682447
SIC: 2835 In Vitro & In Vivo Diagnostic Substances